These observations have led our group to contemplate the contribution of hepsin to the hypercoagulable state of malignancy which, together with other clinical and biological risk factors that converge in cancer patients, ultimately promote the activation of the hemostatic system (Kim et al., 2020; Mahajan et al., 2022). This evidence concerns the gene HPN and cancer.